FMR LLC 13D/13G Filings for Ambrx Biopharma Inc. (AMAM)

FMR LLC 13D and 13G filings for Ambrx Biopharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-09
09:28 am
Purchase
2024-02-0813GAmbrx Biopharma Inc.
AMAM
FMR LLC1,474,258
2.334%
1,474,258increase
(New Position)
Filing